
Filippo Dall'Olio
@filippodallolio
M.d., PhD, medical oncologist
Gustave Roussy
ID: 479396264
31-01-2012 10:18:54
89 Tweet
179 Followers
156 Following


Hard to believe this work started 6 years ago, when we felt AI-digital pathology could enhance PD-L1 assessment in NSCLC, ahead of its time! I'm glad it's finally seeing the light 👇💫👇 @raffaelegiusti Marco Filetti Emilio Bria Filippo Dall'Olio pathologica.it/article/view/9…

What happens in the tumor and in the host when tumor burden increases? Could we use tMTV to decide when intensify the treatment in aNSCLC? We tried to answer these questions in our multicentric effort Benjamin Besse Gustave Roussy







#ELCC25 De-escalation clinical trials in NSCLC Impassioned presentation of the key trials, that can save pt’s time, toxicity, & ensure healthcare system sustainability - PULSE 🇫🇷 - Osi-Save 🇳🇱 - REFINE-Lung 🇬🇧 Benjamin Besse, best in the business ESMO - Eur. Oncology OncoAlert #LCSM


Great presentation by Benjamin Besse on de-escalation. What does it mean? Why is it crucial for both clinicians and patients? And why should regulatory agencies support de-escalation trials? #oncology #medicalresearch #ELCC25


presenting our poster about CtDNA to predict ICI outcome in HNSCC and biological correlates. Come and see! Gustave Roussy #unicancer Conquer Cancer, the ASCO Foundation ASCO #asco2025 #HNSCC

